Yuling Lai

Yuling Lai

Auto-generated profile, based on publicly available information

Yuling Lai

Guangzhou University of Chinese Medicine, Guangzhou, 510405, People's Republic of China; Guangzhou Sport University, Guangzhou, 510500, People's Republic of China

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
YLYuling Lai
Yuling Lai
YZYu Zhang
Yu Zhang
HZHuimin Zhang
Huimin Zhang
ZCZhenyue Chen
Zhenyue Chen
LZLihua Zeng
Lihua Zeng
JGJie Gao
Jie Gao

1 July 2022 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
YLYuling Lai
Yuling Lai
FZFuling Zeng
Fuling Zeng
ZCZhenyue Chen
Zhenyue Chen
MFMin Feng
Min Feng
YHYanxi Huang
Yanxi Huang
JGJie Gao
Jie Gao
Background: Albeit oxidative stress has been implied in the pathogenesis of tubal pregnancy (TP), there are scant data to suggest that ferroptosis occurs in TP. Shikonin plays a pivotal role in redox status, but whether it can regulate ferroptosis to treat TP remains unknown. Methods: We collected and analyzed ferroptosis-related indices from the villous tissue (VT) of women suffering from TP and from women with a normal pregnancy. In vitro, we used shikonin and/or RAS-selective lethal 3 (RSL3) to intervene HTR-8/SVneo cells and further detected ferroptosis indices and cell functions. Finally, the expression of the nuclear factor erythroid 2-related factor 2 (Nrf2) is pharmacologically activated to explore the effect of Nrf2 on shikonin regulating ferroptosis. Results: Increased malondialdehyde content, reduced levels of glutathione and glutathione peroxidase (GPx), and upregulated protein expression which promoted ferroptosis were observed in the VT of TP patients, suggesting that ferroptosis occurred during TP. In vitro, shikonin enhanced ferroptosis sensitivity in HTR-8/SVneo cells induced by RSL3 via amplifying lipid peroxidation, which mainly included increasing cellular reactive oxygen species (ROS), lipid ROS and Fe2+ level. RSL3 and/or shikonin inhibited Nrf2 and downregulated protein expression of SLC7A11 and GPx4 caused by RSL3 + shikonin co-treatment, which could be reversed under activation of Nrf2. Hence, shikonin facilitated lipid peroxidation by inhibiting Nrf2 signaling. Additionally, shikonin and/or RSL3 potently inhibited the invasion and migration of HTR-8/SVneo cells. Conclusion: This study firstly showed that ferroptosis may be involved in TP pathogenesis and shikonin potentially targeted ferroptosis to treat TP.

1 May 1997 in The Journal of Maternal-Fetal Medicine
Verified
Journal Article
Closed access
PDF file
FCFrancis J. Cioffi
Francis J. Cioffi
LALouis F. Amorosa
Louis F. Amorosa
AVAnthony M. Vintzileos
Anthony M. Vintzileos
YLYu‐Ling Lai
Yu‐Ling Lai
MLMarian F. Lake
Marian F. Lake
VRVincent A. Rifici
Vincent A. Rifici